Exactitud de los parámetros antropométricos como indicadores de adiposidad visceral previstos para ecuación bidimensional / Accuracy parameters as indicators of anthropometric adiposity visceral scheduled for two-dimensional equation

Introducción: los indicadores antropométricos son fáciles de aplicar y pueden ayudar en la identificación de la acumulación de grasa visceral, lo que favorece la aparición de eventos cardiovasculares, así como, el aumento de la morbilidad y mortalidad por enfermedades crónicas. Objetivo: evaluar la exactitud de los indicadores antropométricos de distribución de la grasa abdominal para determinar la adiposidad visceral. Sujetos/Métodos: estudio transversal realizado con pacientes ambulatorios, de ambos sexos, mayores de 20 años. Fueron evaluados: circunferencia de la cintura (CC); relación cintura-cadera (WHR); cintura-altura (CER); índice Taper (CI); diámetro abdominal sagital (DAS); (DC) de diámetro coronal; índice de masa corporal (IMC); porcentaje de grasa corporal (% GC); adiposidad visceral (AV/AS) predicha por la fórmula; glucosa en sangre en ayunas; colesterol total (TC); lipoproteína de baja densidad (LDL); lipoproteína de alta densidad (HDL); lipoproteínas de muy baja densidad (VLDL) y triglicéridos (TG). Resultados: se evaluaron 129 pacientes, edad media 51, 06 + 14,02 años y una mayor prevalencia de adultos (72,9%) y mujeres (75,2%). CC 102,9 (+ 10,82), HF 2,08 (± 0,13) y AV/AS 1,03 (+ 0,16), mostraron valores altos con significación estadística entre los hombres, p < 0,001. Lo mismo ocurrió con la CT (+ 46,4 212,41), HDL (50,15 + 13,24) y LDL (135,62 + 40,16) entre las mujeres, p < 0,05. DC, RCE, DAS y DC mostraron una correlación inversa y significativa con la AV/AS: r = -0,364; -0.457; -0.403; -0.296; -0.475, respectivamente, p < 0,001. Sin embargo, que mejor explicó la varianza de la obesidad visceral fueron el DC (R² = 0,77), CQ (R² = 0,64) y RCE (R² = 0,59). Discusión/Conclusión: la DC y el CER fueron los mejores predictores para las mediciones antropométricas de la obesidad visceral (AU)

Introduction: anthropometric indicators are easy to apply and can help identify the accumulation of visceral fat, which favors the occurrence of cardiovascular events, increasing morbidity and mortality from chronic degenerative diseases. Objective: to evaluate the accuracy of anthropometric indicators for the location of abdominal fat in determining visceral adiposity. Subjects/Methods: cross-sectional study conducted among patients attending outpatient, of both sexes, aged over 20 years. Evaluated: Waist Circumference (WC), Waist-Hip Ratio (WHR), waist-to- stature ratio (CER), conicity index (CI); Sagittal Abdominal Diameter (DAS); Coronal Diameter (DC); Mass Index (BMI), percentage of body fat (% BF); Visceral Adiposity (AV/AS) predicted by the formula , fasting glucose , total cholesterol (TC), Low Density Lipoprotein (LDL), high density lipoprotein (HDL), Very Low Density lipoprotein (VLDL) and Triglycerides (TG). Results: 129 patients were included, mean age 51, 06 + 14.02 years and a higher prevalence of adults (72,9%) and female (75,2%). CC 102,9 (+ 10,82 ), CI 2,08 (+ 0,13), and the AV/AS 1,03 (+ 0,16), showed high values with statistical significance among men, p<0.001 . The same occurred with the CT (212,41 + 46,4), HDL (50,15 + 13,24) and LDL (135,62 + 40,16) among women, p<0.05. The CC, RCE, DAS and DC showed an inverse and significant correlation with the AV/AS: r = -0,364; -0,457; -0,403; -0,296; -0,475; respectively, p<0.001. However, best explained the variance in visceral obesity were the DC (R² = 0.77), CQ (R² = 0.64) and CERs (R² = 0.59). Discusión/Conclusion: the DC and CERs were the best predictors anthropometric measures of visceral obesity (AU)

Drug/nutrition interaction in the developing brain: dipyrone enhances spreading depression in rats.

The abuse of pharmaceutical drugs and the inadequate ingestion of nutrients constitute external factors that can alter brain development, both individually and in combination. We used cortical spreading depression (CSD) as a neurophysiological parameter to investigate the combined effects of the antipyretic/analgesic/anti-inflammatory drug dipyrone and malnutrition (M) in the developing rat brain. Suckling malnourished rats (M; n=69) and well nourished controls (W; n=76) received dipyrone (300 mg/kg/day) or saline per gavage for 7 consecutive days during the 2nd, 3rd, or 4th postnatal week. At 35-45 days, CSD was recorded at 2 points in the parietal region. In both groups, dipyrone increased CSD propagation velocities compared to respective saline controls (P<0.05). This effect was intensified when dipyrone application during the 4th postnatal week intensified the increase compared to the 2nd and 3rd weeks. In saline-treated groups, the velocities (mean+/-s.d., in mm/min) were 3.70+/-0.11, 3.77+/-0.16, and 3.78+/-0.13 (W) and 4.13+/-0.10, 4.16+/-0.10, and 4.14+/-0.09 (M), for animals treated in the 2nd, 3rd and 4th postnatal weeks. In dipyrone-treated groups, the respective values were 3.99+/-0.14, 4.03+/-0.16, and 4.30+/-0.19 (W) and 4.47+/-0.17, 4.70+/-0.31, and 5.01+/-0.28 (M). Results support the hypothesis that dipyrone has a CSD-facilitating effect, which is more intense at a late brain developmental stage and is facilitated by malnutrition. This may help explain the developmental brain excitability changes that are associated with pharmacological and nutritional factors.